A case report of a CLL patient19 also identified a mutation in ASXL1 gene after FCR treatment, and other studies focused on acute myeloid leukaemia and myelodysplastic syndrome have identified mutations in ASXL1 after treatment with chemotherapy20–22. This evidence concerns the gene ASXL1 and acute myeloid leukemia.